NRXP
NRXP
NASDAQ · Pharmaceuticals

Nrx Pharmaceuticals Inc

$3.85
-0.05 (-1.28%)
As of Jun 23, 5:00 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +452.7% upside
Low Target $14.65
Average Target $21.28
High Target $27.46
Current Price $3.85
Current
$3.85
Target
$21.28
$14.65 $21.28 avg $27.46
Scenario Analysis
Bear Case
$14.65
280.5%
Low target
Base Case
$21.28
+452.7%
Avg target
Bull Case
$27.46
+613.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.06
-23.8% from high
52-Week Low
$1.62
+137.7% from low
Target vs 52W High
$21.28
+321.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.4%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.7%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +31.4%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +40.7%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%